Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. (Q46117432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Rona M Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Mary-Jane Guerry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Simona Laurino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Fausta Catapano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Afzal Chaudhry

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kenneth G C Smith

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

David R W Jayne

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

1 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

3760-3769

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22729997%20AND%20SRC:MED&resulttype=core&format=json

Long-term follow-up study of periarteritis nodosa.

6 February 2020

cites work

1 reference

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

21 January 2018

1 reference

Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study

21 January 2018

1 reference

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

21 January 2018

1 reference

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

21 January 2018

1 reference

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis

21 January 2018

1 reference

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

21 January 2018

1 reference

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis.

21 January 2018

1 reference

Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trial

21 January 2018

1 reference

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

21 January 2018

1 reference

EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

21 January 2018

1 reference

Rituximab as maintenance therapy for anti-neutrophil cytoplasmic antibody-associated vasculitis

21 January 2018

1 reference

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial

21 January 2018

1 reference

Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells.

21 January 2018

1 reference

Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis

21 January 2018

1 reference

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies

21 January 2018

1 reference

EULAR recommendations for the management of primary small and medium vessel vasculitis.

21 January 2018

1 reference

Long-term follow-up of relapsing/refractory anti-neutrophil cytoplasm antibody associated vasculitis treated with the lymphocyte depleting antibody alemtuzumab (CAMPATH-1H).

21 January 2018

1 reference

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis

21 January 2018

1 reference